Back

Xenon Pharmaceuticals to present at Wells Fargo Healthcare Conference Sept. 9

Verifying
  • Xenon Pharmaceuticals will present at the Wells Fargo Healthcare Conference in Boston.
  • September 9, 2026, features an 11:00–11:30 a.m. ET fireside chat.
  • Xenon’s azetukalner is in late-stage development for epilepsy and depressive disorders.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.